Publications by authors named "ML Owens"

Claim this Profile
C
Counterevidence of crime-reduction effects from federal grants of military equipment to local police.
Anna Gunderson, Elisha Cohen, Kaylyn Jackson Schiff, Tom S Clark, Adam N Glynn, Michael Leo Owens

Nat Hum Behav· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to editor on "Comparison between circular- and linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass - a cohort from the Scandinavian Obesity Registry".
Milton L Owens

Surg Obes Relat Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD data 2008-2011.
John P Sczepaniak, Milton L Owens, Heena Shukla, John Perlegos, William Garner

Obes Surg· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simpler method for predicting weight loss in the first year after Roux-en-Y gastric bypass.
John P Sczepaniak, Milton L Owens, William Garner, Farouk Dako, Kristin Masukawa

J Obes· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain.
Robert J Coffey, Mary L Owens, Steven K Broste, Michel Y Dubois, F Michael Ferrante

Pain Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain.
Robert J Coffey, Mary L Owens, Steven K Broste, Michel Y Dubois, F Michael Ferrante

Anesthesiology· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Size really does matter-role of gastrojejunostomy in postoperative weight loss.
Milton L Owens, John P Sczepaniak

Surg Obes Relat Dis· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of gastrojejunal anastomotic technique designed to reduce stricture.
John P Sczepaniak, Milton L Owens

Surg Obes Relat Dis· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDI2, a second isopentenyl diphosphate isomerase in mammals.
Daun B Clizbe, Michelle L Owens, Kimberly R Masuda, Janis E Shackelford, Skaidrite K Krisans

J Biol Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
Lester I Harrison, Shari L Skinner, Thomas C Marbury, Mary L Owens, Sarala Kurup

Arch Dermatol Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
Daniel N Sauder, Robert B Skinner, Terry L Fox, Mary L Owens

Sex Transm Dis· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
R Marks, K Gebauer, S Shumack, M Amies, J Bryden, M L Owens

J Am Acad Dermatol· May 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
K H Fife, A Ferenczy, J M Douglas, D R Brown, M Smith, M L Owens

Sex Transm Dis· April 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod 5% cream in the treatment of Bowen's disease.
A Mackenzie-Wood, S Kossard, J de Launey, B Wilkinson, M L Owens

J Am Acad Dermatol· March 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand.
K L Serrao, J D Fortenberry, M L Owens, F L Harris, L A Brown

Am J Physiol Lung Cell Mol Physiol· February 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S-nitrosoglutathione inhibits TNF-alpha-induced NFkappaB activation in neutrophils.
J D Fortenberry, M L Owens, N X Chen, L A Brown

Inflamm Res· February 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream.
K R Beutner, J K Geisse, D Helman, T L Fox, A Ginkel, M L Owens

J Am Acad Dermatol· December 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
R J Gilson, J L Shupack, A E Friedman-Kien, M A Conant, J N Weber, M L Owens

AIDS· December 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of exogenous nitric oxide and hyperoxia on lung fibroblast viability and DNA fragmentation.
N Raghuram, J D Fortenberry, M L Owens, L A Brown

Biochem Biophys Res Commun· September 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S-nitrosoglutathione enhances neutrophil DNA fragmentation and cell death.
J D Fortenberry, M L Owens, L A Brown

Am J Physiol· March 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod applied topically: a novel immune response modifier and new class of drug.
R L Miller, J F Gerster, M L Owens, H B Slade, M A Tomai

Int J Immunopharmacol· January 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous penetration of Aldara cream, 5% during the topical treatment of genital and perianal warts.
ML Owens, WE Bridson, SL Smith, JA Myers, TL Fox

Prim Care Update Ob Gyns· July 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of action of imiquimod 5% cream in the treatment of anogenital warts.
SK Tyring, I Arany, MA Stanley, MH Stoler, MA Tomai, ML Owens

Prim Care Update Ob Gyns· July 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod 5% cream (Aldara).
H B Slade, M L Owens, M A Tomai, R L Miller

Expert Opin Investig Drugs· March 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis